B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event In a randomised, prospective, single-institutional, consecutive cohort study of 60 patients with locally advanced unresectable non-small cell lung carcinoma (NSCLC) enrolled from December 2013 to December 2014, one patient [ I age and sex not stated i ] was described, who developed pneumonitis following neoadjuvant chemotherapy with cisplatin and paclitaxel for locally advanced unresectable NSCLC. The patient who had locally advanced unresectable NSCLC received 4 cycles of neoadjuvant chemotherapy consisting of cisplatin injection 75 mg/m SP 2 sp divided into day 1 and day 2 and IV paclitaxel injection 175 mg/m SP 2 sp on day 1, repeated every 3 weeks [ I not all routes stated i ]. Neo-adjuvant chemotherapy followed by either continuous hyper-fractionated accelerated radiation therapy week-end less or conventional chemo-radiotherapy in locally advanced NSCLC-A randomised prospective single institute study. [Extracted from the article]
Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
